BRAF and neoplasm: In this manner, our melanoma mouse model is ideal for the study of tumor dormancy and resistance, both to BRAF and MEK inhibition, and is well suited to determine and validate additional genetic alterations found in recurrent tumors that may be responsible for resistance and regrowth.